CD276 and breast cancer: To examine in vivo activity of B7H3.CAR EBVST in systems that more accurately represent biology of human cancers, we used a breast cancer PDX characterized by a heterogenous moderate to high B7-H3 expression pattern, with discrete regions displaying varying levels of B7-H3 protein (Fig. 4E).